I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with extensive experience in technology and innovation within the industry. With a strong background in research and development, Ivan has been at the forefront of integrating cutting-edge solutions like machine learning into
In a world where medical advancements are reshaping everyday procedures, consider the possibility of undergoing cataract surgery not in a daunting hospital setting, but in the familiar comfort of a doctor’s office, with just a simple pill to calm the nerves. This isn’t a far-fetched idea but a
In a groundbreaking shift for medical research, the United Kingdom has dramatically reduced the time it takes to approve clinical trials, cutting the average review period from a lengthy 91 days to an impressive 41 days. This remarkable achievement, driven by the integration of artificial
In an era where childhood obesity has emerged as a significant public health challenge, innovative solutions are urgently needed to address this growing epidemic, which affects millions of children worldwide. Recent statistics paint a stark picture: countless young individuals are at risk of
The biotechnology sector often rides a rollercoaster of high hopes and sharp setbacks, and few cases illustrate this better than the recent plunge in Exelixis’ stock value following the release of data from its STELLAR-303 trial. Focused on zanzalintinib, an experimental drug for metastatic
As we dive into the complex world of healthcare policy, I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert whose deep understanding of technology and innovation in the industry, coupled with extensive experience in research and development, offers invaluable insights. Today,
